Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Transcatheter Versus Standard Surgical Mitral Valve Operation for Secondary Mitral Regurgitation

NCT: NCT05090540 · ENROLLING_BY_INVITATION

NCT IDNCT05090540
StatusENROLLING_BY_INVITATION
Start Date2017-06-01
Completion2026-12-30
SponsorCentre Cardiologique du Nord (OTHER)
First posted
Last updated

Brief Summary

The mechanical intervention is treating secondary mitral regurgitation (SMR) which may be performed using the standard open surgical approach or transcatheter edge to edge repair (TEER). The key question of this study is to establish the difference in left ventricular reverse remodeling after adjustment for death, as assessed by means of the left ventricular end-systolic dimension(LVESD), all-cause and cause-specific (cardiac vs noncardiac) mortality in patients who received the TEER vs the standard surgical procedure for SMR.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑